EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P29
Within normal range
vs 5Y Ago
-0.9x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-36.64%
2024-27.47%
202333.58%
2022-34.98%
202142.66%
202041.39%
201947.48%
2018-119.89%
201723.20%
2016-415.28%